KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Common Equity: 2010-2025

Historic Common Equity for Opko Health (OPK) over the last 14 years, with Sep 2025 value amounting to $1.3 billion.

  • Opko Health's Common Equity fell 6.98% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 6.98%. This contributed to the annual value of $1.4 billion for FY2024, which is 1.71% down from last year.
  • According to the latest figures from Q3 2025, Opko Health's Common Equity is $1.3 billion, which was up 0.66% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Opko Health's Common Equity peaked at $1.8 billion during Q3 2021, and registered a low of $1.3 billion during Q1 2024.
  • In the last 3 years, Opko Health's Common Equity had a median value of $1.4 billion in 2023 and averaged $1.4 billion.
  • As far as peak fluctuations go, Opko Health's Common Equity climbed by 9.71% in 2021, and later decreased by 19.27% in 2024.
  • Quarterly analysis of 5 years shows Opko Health's Common Equity stood at $1.7 billion in 2021, then fell by 7.33% to $1.6 billion in 2022, then dropped by 11.04% to $1.4 billion in 2023, then dropped by 1.71% to $1.4 billion in 2024, then decreased by 6.98% to $1.3 billion in 2025.
  • Its Common Equity was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.